Sarcoid-Like Granulomatosis Induced by Nivolumab Treatment in a Lung Cancer Patient

Nivolumab, an anti-PD-1 antibody, inhibits binding between PD-1 and PD-1 ligand and activates antigen-specific T cells that have become unresponsive to cancer cells. Although it is recommended as a second-line therapy in gene mutation-negative non-small-cell lung cancer, interstitial pneumonia is a...

Full description

Bibliographic Details

Main Authors:	Susumu Noguchi, Hiroaki Kawachi, Hiroshi Yoshida, Akari Fukao, Satoshi Terashita, Tatsuyoshi Ikeue, Sadao Horikawa, Takakazu Sugita
Format:	Artigo
Language:	Inglês
Published:	Karger Publishers 2018-08-01
Series:	Case Reports in Oncology
Subjects:	Nivolumab Sarcoid-like granulomatosis Lung cancer Pleomorphic carcinoma
Online Access:	https://www.karger.com/Article/FullText/492383
Tags:	Add Tag No Tags, Be the first to tag this record!